KATIE FOWLER: Open Payments
NPI 1841057270 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,596 in 64 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,262 · 2025 $1,596
Food & beverage: $1,512Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $514 |
| Phathom Pharmaceuticals, Inc. | 10 | $170 |
| Ipsen Biopharmaceuticals, Inc | 2 | $157 |
| Janssen Biotech, Inc. | 3 | $128 |
| Madrigal Pharmaceuticals | 5 | $123 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| Ardelyx, Inc. | 3 | $82 |
| EVOKE PHARMA, INC. | 4 | $74 |
| Aimmune Therapeutics, Inc. | 3 | $59 |
| Celltrion USA Inc. | 3 | $52 |
Products named: SKYRIZI, VOQUEZNA, IQIRVO, CREON, TREMFYA, REZDIFFRA, DUPIXENT, RINVOQ.
Industry payments across TX — which companies pay providers there.
